Literature DB >> 31126316

Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia.

Yan Liu1,2,3, Zhiheng Cheng4, Yifan Pang5, Longzhen Cui2, Tingting Qian1,3, Liang Quan1,3, Hongyou Zhao6, Jinlong Shi7, Xiaoyan Ke8, Lin Fu9,10,11.   

Abstract

Acute myeloid leukemia (AML) is a malignant tumor of the immature myeloid hematopoietic cells in the bone marrow (BM). It is a highly heterogeneous disease, with rising morbidity and mortality in older patients. Although researches over the past decades have improved our understanding of AML, its pathogenesis has not yet been fully elucidated. Long noncoding RNAs (lncRNAs), microRNAs (miRNAs), and circular RNAs (circRNAs) are three noncoding RNA (ncRNA) molecules that regulate DNA transcription and translation. With the development of RNA-Seq technology, more and more ncRNAs that are closely related to AML leukemogenesis have been discovered. Numerous studies have found that these ncRNAs play an important role in leukemia cell proliferation, differentiation, and apoptosis. Some may potentially be used as prognostic biomarkers. In this systematic review, we briefly described the characteristics and molecular functions of three groups of ncRNAs, including lncRNAs, miRNAs, and circRNAs, and discussed their relationships with AML in detail.

Entities:  

Keywords:  Acute myeloid leukemia; Long noncoding RNA; circRNA; microRNA

Mesh:

Substances:

Year:  2019        PMID: 31126316      PMCID: PMC6534901          DOI: 10.1186/s13045-019-0734-5

Source DB:  PubMed          Journal:  J Hematol Oncol        ISSN: 1756-8722            Impact factor:   17.388


  196 in total

1.  MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.

Authors:  Shun Ke; Rui-Chao Li; Jun Lu; Fan-Kai Meng; Yi-Kuan Feng; Ming-Hao Fang
Journal:  Int J Hematol       Date:  2017-04-13       Impact factor: 2.490

2.  miR-223 decreases cell proliferation and enhances cell apoptosis in acute myeloid leukemia via targeting FBXW7.

Authors:  Yi Xiao; Changliang Su; Taoran Deng
Journal:  Oncol Lett       Date:  2016-09-09       Impact factor: 2.967

3.  Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.

Authors:  Qi Wang; Tao Feng; Jun Xu; Mei-Hua Miao; Xue-Qiang Ji; Hong Zhu; Xue-Jun Shao
Journal:  J Cell Physiol       Date:  2018-08-31       Impact factor: 6.384

Review 4.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

5.  Long noncoding RNA UCA1 promotes cell proliferation, migration and invasion of human leukemia cells via sponging miR-126.

Authors:  M-D Sun; Y-Q Zheng; L-P Wang; H-T Zhao; S Yang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-04       Impact factor: 3.507

6.  Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients.

Authors:  Aleksandra Butrym; Justyna Rybka; Dagmara Baczyńska; Andrzej Tukiendorf; Kazimierz Kuliczkowski; Grzegorz Mazur
Journal:  J Exp Clin Cancer Res       Date:  2015-07-01

7.  High level of miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcome.

Authors:  Lihua Xu; Yang Guo; Wenying Yan; Jiannong Cen; Yuna Niu; Qing Yan; Hailong He; Chien-Shing Chen; Shaoyan Hu
Journal:  EXCLI J       Date:  2017-03-07       Impact factor: 4.068

8.  MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia.

Authors:  Jens-Uwe Hartmann; Daniela Bräuer-Hartmann; Miroslava Kardosova; Alexander A Wurm; Franziska Wilke; Cindy Schödel; Dennis Gerloff; Christiane Katzerke; Rosanna Krakowsky; Carolina Yaeko Namasu; Marius Bill; Sebastian Schwind; Carsten Müller-Tidow; Dietger Niederwieser; Meritxell Alberich-Jorda; Gerhard Behre
Journal:  Cell Death Dis       Date:  2018-07-26       Impact factor: 8.469

9.  microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells.

Authors:  Elena Vigorito; Kerry L Perks; Cei Abreu-Goodger; Sam Bunting; Zou Xiang; Susan Kohlhaas; Partha P Das; Eric A Miska; Antony Rodriguez; Allan Bradley; Kenneth G C Smith; Cristina Rada; Anton J Enright; Kai-Michael Toellner; Ian C M Maclennan; Martin Turner
Journal:  Immunity       Date:  2007-12-06       Impact factor: 31.745

10.  miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1.

Authors:  Yi Zhang; Shu-yan Zhou; Hai-zhao Yan; Dan-dan Xu; Hai-xuan Chen; Xiao-yan Wang; Xiao Wang; Yu-ting Liu; Li Zhang; Sheng Wang; Peng-jun Zhou; Wu-yu Fu; Bi-bo Ruan; Dong-lei Ma; Ying Wang; Qiu-ying Liu; Zhe Ren; Zhong Liu; Rong Zhang; Yi-fei Wang
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

View more
  55 in total

1.  Circ-SFMBT2 facilitates the malignant growth of acute myeloid leukemia cells by modulating miR-582-3p/ZBTB20 pathway.

Authors:  Wei Chang; Zhen Shang; Xi Ming; Jiaying Wu; Yi Xiao
Journal:  Histol Histopathol       Date:  2021-11-26       Impact factor: 2.303

2.  Circ_0035381 Regulates Acute Myeloid Leukemia Development by Modulating YWHAZ Expression via Adsorbing miR-582-3p.

Authors:  Feng Xue; Min Li; Yun Liu; Chunxin Xu; Haigang Li; Huilian Liu
Journal:  Biochem Genet       Date:  2022-08-02       Impact factor: 2.220

3.  Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.

Authors:  Airong Wang; Yufei Chen; Luyao Shi; Mengya Li; Lingling Li; Shujuan Wang; Chong Wang
Journal:  J Transl Med       Date:  2022-06-27       Impact factor: 8.440

Review 4.  Tip of the iceberg: roles of circRNAs in hematological malignancies.

Authors:  Shan-Shan Guo; Bi-Xia Li; Duo-Bing Zou; Shu-Jun Yang; Li-Xia Sheng; Gui-Fang Ouyang; Qi-Tian Mu; He Huang
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

Review 5.  PRDM16 Regulating Adipocyte Transformation and Thermogenesis: A Promising Therapeutic Target for Obesity and Diabetes.

Authors:  Na Jiang; Ming Yang; Yachun Han; Hao Zhao; Lin Sun
Journal:  Front Pharmacol       Date:  2022-04-08       Impact factor: 5.988

6.  Long Noncoding RNA Maternally Expressed Gene 3 Is Downregulated, and Its Insufficiency Correlates With Poor-Risk Stratification, Worse Treatment Response, as Well as Unfavorable Survival Data in Patients With Acute Myeloid Leukemia.

Authors:  Chunling He; Xinmei Wang; Jing Luo; Yinghua Ma; Zhen Yang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

7.  Long non-coding RNA LINC01268 promotes cell growth and inhibits cell apoptosis by modulating miR-217/SOS1 axis in acute myeloid leukemia.

Authors:  Beili Chen; Yuchuan Li; Yuwei Nie; Ailin Tang; Qin Zhou
Journal:  Braz J Med Biol Res       Date:  2020-06-26       Impact factor: 2.590

8.  The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.

Authors:  Wen-Tao Wang; Tian-Qi Chen; Zhan-Cheng Zeng; Qi Pan; Wei Huang; Cai Han; Ke Fang; Lin-Yu Sun; Qian-Qian Yang; Dan Wang; Xue-Qun Luo; Yu-Meng Sun; Yue-Qin Chen
Journal:  J Hematol Oncol       Date:  2020-06-17       Impact factor: 17.388

9.  Identification of A-kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia.

Authors:  Yan Yan; Xiaoyan Li; Jie Gao
Journal:  J Clin Lab Anal       Date:  2020-05-01       Impact factor: 2.352

Review 10.  Roles of hsa-miR-12462 and SLC9A1 in acute myeloid leukemia.

Authors:  Yan Jia; Wei Liu; Hui-En Zhan; Xiao-Ping Yi; Hui Liang; Qi-Li Zheng; Xin-Ya Jiang; Hai-Yan Zhou; Liang Zhao; Xie-Lan Zhao; Hui Zeng
Journal:  J Hematol Oncol       Date:  2020-07-23       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.